These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10626557)

  • 1. Body composition in Prader-Willi syndrome: assessment and effects of growth hormone administration.
    Davies PS
    Acta Paediatr Suppl; 1999 Dec; 88(433):105-8. PubMed ID: 10626557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatropin therapy in adults with Prader-Willi syndrome.
    Höybye C; Thorén M
    Treat Endocrinol; 2004; 3(3):153-60. PubMed ID: 16026111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle characteristics and motor performance after 2-year growth hormone treatment in adults with prader-willi syndrome.
    Lafortuna CL; Minocci A; Capodaglio P; Gondoni LA; Sartorio A; Vismara L; Rizzo G; Grugni G
    J Clin Endocrinol Metab; 2014 May; 99(5):1816-24. PubMed ID: 24471571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body composition during GH treatment in Prader-Labhardt-Willi syndrome.
    Bosio L; Beccaria L; Benzi F; Sanzari A; Chiumello G
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():351-3. PubMed ID: 10698601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome.
    Davies PS; Evans S; Broomhead S; Clough H; Day JM; Laidlaw A; Barnes ND
    Arch Dis Child; 1998 May; 78(5):474-6. PubMed ID: 9659098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group.
    Ritzén EM; Lindgren AC; Hagenäs L; Marcus C; Müller J; Blichfeldt S
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():345-9. PubMed ID: 10698600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Pediatr Endocrinol Metab; 2001; 14(8):1097-105. PubMed ID: 11592566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone therapy in Prader-Willi syndrome.
    Davies PS
    Int J Obes Relat Metab Disord; 2001 Jan; 25(1):2-7. PubMed ID: 11244451
    [No Abstract]   [Full Text] [Related]  

  • 11. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
    Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
    Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone treatment improves body composition in adults with Prader-Willi syndrome.
    Höybye C; Hilding A; Jacobsson H; Thorén M
    Clin Endocrinol (Oxf); 2003 May; 58(5):653-61. PubMed ID: 12699450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Pediatr; 1999 Feb; 134(2):215-21. PubMed ID: 9931532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome.
    Haqq AM; Stadler DD; Jackson RH; Rosenfeld RG; Purnell JQ; LaFranchi SH
    J Clin Endocrinol Metab; 2003 May; 88(5):2206-12. PubMed ID: 12727976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition abnormalities in children with Prader-Willi syndrome and long-term effects of growth hormone therapy.
    Eiholzer U; l'Allemand D; van der Sluis I; Steinert H; Gasser T; Ellis K
    Horm Res; 2000; 53(4):200-6. PubMed ID: 11044804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC; Lindberg A
    Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone treatment for Prader-Willi syndrome: A review.
    Yang X
    Neuropeptides; 2020 Oct; 83():102084. PubMed ID: 32859387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 6 months of growth hormone treatment in young children with Prader-Willi syndrome.
    Eiholzer U; Weber R; Stutz K; Steinert H
    Acta Paediatr Suppl; 1997 Nov; 423():66-8. PubMed ID: 9401543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone treatment of Prader-Willi syndrome has long-term, positive effects on body composition.
    Höybye C
    Acta Paediatr; 2015 Apr; 104(4):422-7. PubMed ID: 25557351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome.
    Gondoni LA; Vismara L; Marzullo P; Vettor R; Liuzzi A; Grugni G
    J Endocrinol Invest; 2008 Sep; 31(9):765-72. PubMed ID: 18997487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.